These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 34344721)

  • 1. Heart failure in pregnancy: what is the long-term impact of pregnancy on cardiac function? A tertiary care centre experience and systematic review.
    Dodeja AK; Siegel F; Dodd K; Ma'ayeh M; Mehta LS; Fuchs MM; Rood KM; Mah ML; Bradley EA
    Open Heart; 2021 Aug; 8(2):. PubMed ID: 34344721
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical Outcomes for Peripartum Cardiomyopathy in North America: Results of the IPAC Study (Investigations of Pregnancy-Associated Cardiomyopathy).
    McNamara DM; Elkayam U; Alharethi R; Damp J; Hsich E; Ewald G; Modi K; Alexis JD; Ramani GV; Semigran MJ; Haythe J; Markham DW; Marek J; Gorcsan J; Wu WC; Lin Y; Halder I; Pisarcik J; Cooper LT; Fett JD;
    J Am Coll Cardiol; 2015 Aug; 66(8):905-14. PubMed ID: 26293760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Echocardiographic Assessments for Peripartum Cardiac Events in Pregnant Women with Low-Risk Congenital Heart Disease.
    Fukumitsu A; Muneuchi J; Watanabe M; Sugitani Y; Kawakami T; Ito K
    Int Heart J; 2021 Sep; 62(5):1062-1068. PubMed ID: 34544966
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term outcome in patients with Takotsubo syndrome presenting with severely reduced left ventricular ejection fraction.
    Citro R; Radano I; Parodi G; Di Vece D; Zito C; Novo G; Provenza G; Bellino M; Prota C; Silverio A; Antonini-Canterin F; Rigo F; Vriz O; Galasso G; Bossone E; Salerno-Uriarte J; Piscione F
    Eur J Heart Fail; 2019 Jun; 21(6):781-789. PubMed ID: 30714660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bromocriptine treatment in patients with peripartum cardiomyopathy and right ventricular dysfunction.
    Haghikia A; Schwab J; Vogel-Claussen J; Berliner D; Pfeffer T; König T; Zwadlo C; Moulig VA; Franke A; Schwarzkopf M; Ehlermann P; Pfister R; Michels G; Westenfeld R; Stangl V; Kühl U; Podewski E; Kindermann I; Böhm M; Sliwa K; Hilfiker-Kleiner D; Bauersachs J
    Clin Res Cardiol; 2019 Mar; 108(3):290-297. PubMed ID: 30121697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantifying late gadolinium enhancement on CMR provides additional prognostic information in early risk-stratification of nonischemic cardiomyopathy: a cohort study.
    Pöyhönen P; Kivistö S; Holmström M; Hänninen H
    BMC Cardiovasc Disord; 2014 Aug; 14():110. PubMed ID: 25160650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcome of subsequent pregnancies in patients with a history of peripartum cardiomyopathy.
    Hilfiker-Kleiner D; Haghikia A; Masuko D; Nonhoff J; Held D; Libhaber E; Petrie MC; Walker NL; Podewski E; Berliner D; Bauersachs J; Sliwa K
    Eur J Heart Fail; 2017 Dec; 19(12):1723-1728. PubMed ID: 28345302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comparison and analysis of different diagnostic criteria for peripartum cardiomyopathy].
    Wang Y; Gao Z; Liu GL; Wei J; Zhang XH; Wang JL
    Zhonghua Fu Chan Ke Za Zhi; 2011 Jul; 46(7):487-91. PubMed ID: 22041438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peripartum cardiomyopathy in Iraq: initial registry-based data and 6 month outcomes.
    Farhan HA; Yaseen IF
    ESC Heart Fail; 2021 Oct; 8(5):4048-4054. PubMed ID: 34184413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myocardial Damage Detected by Late Gadolinium Enhancement Cardiac Magnetic Resonance Is Uncommon in Peripartum Cardiomyopathy.
    Schelbert EB; Elkayam U; Cooper LT; Givertz MM; Alexis JD; Briller J; Felker GM; Chaparro S; Kealey A; Pisarcik J; Fett JD; McNamara DM;
    J Am Heart Assoc; 2017 Apr; 6(4):. PubMed ID: 28373243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of bromocriptine on left ventricular functional recovery in peripartum cardiomyopathy: insights from the BRO-HF retrospective cohort study.
    Tremblay-Gravel M; Marquis-Gravel G; Avram R; Desplantie O; Ducharme A; Bibas L; Pacheco C; Couture E; Simard F; Poulin A; Malhamé I; Tran D; Rey E; Tournoux F; Harvey L; Sénéchal M; Bélisle P; Descarries L; Farand P; Pranno N; Diaz A; Afilalo J; Ly HQ; Fortier A; Jolicoeur EM;
    ESC Heart Fail; 2019 Feb; 6(1):27-36. PubMed ID: 30565890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term follow-up in peripartum cardiomyopathy patients with contemporary treatment: low mortality, high cardiac recovery, but significant cardiovascular co-morbidities.
    Moulig V; Pfeffer TJ; Ricke-Hoch M; Schlothauer S; Koenig T; Schwab J; Berliner D; Pfister R; Michels G; Haghikia A; Falk CS; Duncker D; Veltmann C; Hilfiker-Kleiner D; Bauersachs J
    Eur J Heart Fail; 2019 Dec; 21(12):1534-1542. PubMed ID: 31724271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the clinical relevance of baseline left ventricular ejection fraction as a predictor of recovery or persistence of severe dysfunction in women in the United States with peripartum cardiomyopathy.
    Goland S; Bitar F; Modi K; Safirstein J; Ro A; Mirocha J; Khatri N; Elkayam U
    J Card Fail; 2011 May; 17(5):426-30. PubMed ID: 21549301
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical predictors of right ventricular dysfunction and association with adverse outcomes in peripartum cardiomyopathy.
    Imran TF; Ataklte F; Khalid M; Lopez D; Mohebali D; Bello NA; Gaziano JM; Djousse L; Arany Z; Sabe MA; French K; Poppas A; Wu WC; Choudhary G
    ESC Heart Fail; 2024 Feb; 11(1):422-432. PubMed ID: 38030384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New insights into peripartum cardiomyopathy using cardiac magnetic resonance imaging.
    Renz DM; Röttgen R; Habedank D; Wagner M; Böttcher J; Pfeil A; Dietz R; Kivelitz D; Elgeti T
    Rofo; 2011 Sep; 183(9):834-41. PubMed ID: 21830182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypertensive disorders in women with peripartum cardiomyopathy: insights from the ESC EORP PPCM Registry.
    Jackson AM; Petrie MC; Frogoudaki A; Laroche C; Gustafsson F; Ibrahim B; Mebazaa A; Johnson MR; Seferovic PM; Regitz-Zagrosek V; Mbakwem A; Böhm M; Prameswari HS; Fouad DA; Goland S; Damasceno A; Karaye K; Farhan HA; Hamdan R; Maggioni AP; Sliwa K; Bauersachs J; van der Meer P;
    Eur J Heart Fail; 2021 Dec; 23(12):2058-2069. PubMed ID: 34114268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Women with peripartum cardiomyopathy have normal ejection fraction, but abnormal systolic strain, during pregnancy.
    Tamrat R; Kang Y; Scherrer-Crosbie M; Levine LD; Arany Z; Lewey J
    ESC Heart Fail; 2021 Aug; 8(4):3382-3386. PubMed ID: 33943010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The relationship between baseline and follow-up left ventricular ejection fraction with adverse events among primary prevention ICD patients.
    Friedman DJ; Fudim M; Overton R; Shaw LK; Patel D; Pokorney SD; Velazquez EJ; Al-Khatib SM
    Am Heart J; 2018 Jul; 201():17-24. PubMed ID: 29910051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GNB3 C825T Polymorphism and Myocardial Recovery in Peripartum Cardiomyopathy: Results of the Multicenter Investigations of Pregnancy-Associated Cardiomyopathy Study.
    Sheppard R; Hsich E; Damp J; Elkayam U; Kealey A; Ramani G; Zucker M; Alexis JD; Horne BD; Hanley-Yanez K; Pisarcik J; Halder I; Fett JD; McNamara DM;
    Circ Heart Fail; 2016 Mar; 9(3):e002683. PubMed ID: 26915373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Burden, predictors and short-term outcomes of peripartum cardiomyopathy in a black African cohort.
    Nabbaale J; Okello E; Kibirige D; Ssekitoleko I; Isanga J; Karungi P; Sebatta E; Zhu ZW; Nakimuli A; Omagino J; Kayima J
    PLoS One; 2020; 15(10):e0240837. PubMed ID: 33085703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.